The audit aims to provide real-world benchmarks and enable patients, providers and commissioners to compare clinical outcomes and key care processes at different centres. This will enable informed decision-making and patient choice. It will also help to identify best practice, areas where changes in the care pathway may be necessary and drive change to improve treatment outcomes. 

• AMD remains the leading cause of sight impairment, despite new treatment options
• It is estimated to affect 700,000 people in the UK with 39,800 patients developing “wet” or neovascular AMD each year
• The number of people with AMD is expected to rise by 60% by 2035
• Prompt diagnosis, initial treatment and continued treatment over several years are vital to maintaining vision and reducing irrecoverable visual loss
• The UK AMD Audit is now in its third year of operation and aims to improve the care patients undergoing AMD treatment receive
• Data as set out in the AMD Audit Data Set  is collected as part of routine clinical care using Electronic Medical Records (EMR) systems in treating hospitals 
• The next data extraction will take place in June 2025